.Attributes Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for introduction of individuals with MASLD as well as dimension of liver end results in cardio-- kidney-- metabolic trials, when information propose mechanistically probable perks and medical safety-- as well as details factors to consider for trial style and regulative commendation.